+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Spirulina Market by Type, Drug Formulation, Application - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 195 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 6012091
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Spirulina Market grew from USD 389.98 million in 2023 to USD 419.91 million in 2024. It is expected to continue growing at a CAGR of 7.77%, reaching USD 658.49 million by 2030.

Spirulina is a biomass of cyanobacteria, commonly consumed as a dietary supplement or whole food, rich in proteins, vitamins, and minerals. The necessity for spirulina arises from its potential health benefits, such as boosting immune responses, reducing cholesterol levels, and providing essential nutrients, especially for those with dietary restrictions. Application-wise, spirulina is used in food and beverages, dietary supplements, cosmetics, and agriculture, harnessing its nutritional attributes widely. The end-use applications span across healthcare, personal care, animal feed, and aquaculture, creating diverse opportunities for integration into various industries.

Market insights indicate that the key drivers of spirulina’s growth are the increasing consumer inclination towards natural and plant-based products and escalating awareness about its health benefits. Additionally, rising veganism and vegetarian populations are propelling demand. Notably, lucrative opportunities exist in the functional foods segment, given the growing consumer focus on health and wellness. Furthermore, research into optimizing spirulina production efficiency and harnessing its usage in new verticals, such as bioplastics, can provide untapped market opportunities. To capitalize on these, businesses can focus on enhancing product innovation and developing cutting-edge processing technologies to improve spirulina applications.

However, limitations such as high production costs and potential contamination risks pose challenges to market expansion. Climatic dependencies for cultivation and limited consumer awareness regarding differentiating quality also hinder growth. Addressing these challenges through technological innovations like photobioreactor systems and enhancing quality standards could be pivotal in mitigating risks.

The best areas of innovation and research in the spirulina market center on improving cultivation technology, exploring novel extraction processes, and expanding into new application domains such as pharmaceuticals and biotechnology. The market's nature is competitive and dynamic, with a lean towards sustainable, eco-friendly products, predicting continued growth driven by both consumer demands and advancements in production technologies.

Understanding Market Dynamics in the Spirulina Market

The Spirulina Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Awareness of natural health benefits of spirulina superfood
    • Importance of Spirulina in cancer treatment
    • High demand for cyanobacteria for weight reduction and personal care
  • Market Restraints
    • High cost of spirulina
  • Market Opportunities
    • Government initiatives for increasing the production of spirulina
    • Introduction of new varieties of natural food colors produced from spirulina
  • Market Challenges
    • Risk of side effects of overconsumption of spirulina

Exploring Porter’s Five Forces for the Spirulina Market

Porter’s Five Forces framework further strengthens the insights of the Spirulina Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Spirulina Market

External macro-environmental factors deeply influence the performance of the Spirulina Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Spirulina Market

The Spirulina Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Spirulina Market

The Spirulina Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Spirulina Market

The Spirulina Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Spirulina Market, highlighting leading vendors and their innovative profiles. These include Algenol Biofuels Inc., Australian Spirulina, Cabassi & Giuriati SpA, Chr. Hansen Holding A/S, DDW The Color House, DIC Corporation, Dongtai City Spirulina Bio-engineering Co., Ltd, DÖHLER GmbH, Earthrise Nutritionals, LLC, Fuqing King Dnarmsa Spirulina Co. Ltd, GNC Holdings, Inc., GNT Holding B.V., Inner Mongolia Rejuve Biotech Co. Ltd., Naturex S.A, and Now Health Group Inc..

Market Segmentation & Coverage

This research report categorizes the Spirulina Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Type
    • Arthrospira Maxima
    • Arthrospira Platensis
  • Drug Formulation
    • Granule & Gelling Agent
    • Liquid
    • Powder
    • Tablet & Capsule
  • Application
    • Animal Feed
    • Cosmetics
    • Food & Beverages
    • Nutraceuticals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Awareness of natural health benefits of spirulina superfood
5.1.1.2. Importance of Spirulina in cancer treatment
5.1.1.3. High demand for cyanobacteria for weight reduction and personal care
5.1.2. Restraints
5.1.2.1. High cost of spirulina
5.1.3. Opportunities
5.1.3.1. Government initiatives for increasing the production of spirulina
5.1.3.2. Introduction of new varieties of natural food colors produced from spirulina
5.1.4. Challenges
5.1.4.1. Risk of side effects of overconsumption of spirulina
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Spirulina Market, by Type
6.1. Introduction
6.2. Arthrospira Maxima
6.3. Arthrospira Platensis
7. Spirulina Market, by Drug Formulation
7.1. Introduction
7.2. Granule & Gelling Agent
7.3. Liquid
7.4. Powder
7.5. Tablet & Capsule
8. Spirulina Market, by Application
8.1. Introduction
8.2. Animal Feed
8.3. Cosmetics
8.4. Food & Beverages
8.5. Nutraceuticals
9. Americas Spirulina Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Spirulina Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Spirulina Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.4. Strategy Analysis & Recommendation
LIST OF FIGURES
FIGURE 1. SPIRULINA MARKET RESEARCH PROCESS
FIGURE 2. SPIRULINA MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SPIRULINA MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SPIRULINA MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 13. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 15. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. SPIRULINA MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 21. SPIRULINA MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
TABLE 1. SPIRULINA MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SPIRULINA MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SPIRULINA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. SPIRULINA MARKET DYNAMICS
TABLE 7. GLOBAL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA MAXIMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL SPIRULINA MARKET SIZE, BY ARTHROSPIRA PLATENSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL SPIRULINA MARKET SIZE, BY GRANULE & GELLING AGENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL SPIRULINA MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL SPIRULINA MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL SPIRULINA MARKET SIZE, BY TABLET & CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL SPIRULINA MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL SPIRULINA MARKET SIZE, BY COSMETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL SPIRULINA MARKET SIZE, BY FOOD & BEVERAGES, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL SPIRULINA MARKET SIZE, BY NUTRACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 32. CANADA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 35. MEXICO SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES SPIRULINA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 49. CHINA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 52. INDIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 58. JAPAN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 76. THAILAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA SPIRULINA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 86. DENMARK SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 89. EGYPT SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 92. FINLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 95. FRANCE SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 98. GERMANY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 113. NORWAY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 116. POLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 119. QATAR SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 131. SPAIN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 140. TURKEY SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM SPIRULINA MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM SPIRULINA MARKET SIZE, BY DRUG FORMULATION, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM SPIRULINA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 147. SPIRULINA MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. SPIRULINA MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Spirulina market, which are profiled in this report, include:
  • Algenol Biofuels Inc.
  • Australian Spirulina
  • Cabassi & Giuriati SpA
  • Chr. Hansen Holding A/S
  • DDW The Color House
  • DIC Corporation
  • Dongtai City Spirulina Bio-engineering Co., Ltd
  • DÖHLER GmbH
  • Earthrise Nutritionals, LLC
  • Fuqing King Dnarmsa Spirulina Co. Ltd
  • GNC Holdings, Inc.
  • GNT Holding B.V.
  • Inner Mongolia Rejuve Biotech Co. Ltd.
  • Naturex S.A
  • Now Health Group Inc.

Methodology

Loading
LOADING...

Table Information